Taming the Wild-Type Gastrointestinal Stromal Tumor: Improved Tissue Culture
- PMID: 34711630
- PMCID: PMC8738134
- DOI: 10.1158/1078-0432.CCR-21-3409
Taming the Wild-Type Gastrointestinal Stromal Tumor: Improved Tissue Culture
Abstract
Wild-type gastrointestinal stromal tumors (WT GIST) are most frequently characterized by succinate dehydrogenase (SDH) deficiency. Reliable ex vivo tumor models have been difficult to develop given the downstream metabolic effects of SDH deficiency. Improved tumor modeling approaches are needed to develop effective systemic treatment options for patients with WT GIST.See related article by Yebra et al., p. 187.
©2021 American Association for Cancer Research.
Comment on
-
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.Clin Cancer Res. 2022 Jan 1;28(1):187-200. doi: 10.1158/1078-0432.CCR-21-2092. Epub 2021 Aug 23. Clin Cancer Res. 2022. PMID: 34426440 Free PMC article.
References
-
- Taguchi T, Sonobe H, Toyonaga S, Yamasaki I, Shuin T, Takano A, et al. Conventional and Molecular Cytogenetic Characterization of a New Human Cell Line, GIST-T1, Established from Gastrointestinal Stromal Tumor. Lab Invest 2002;82(5):663–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
